The i on MSN10d
Britons face paying more for weight-loss jabs... to make them cheaper for Americans
Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...
Contract Pharma3d
CDMOs: Challenges & Opportunities in a Big Year of Change
CDMOs: Challenges & Opportunities in a Big Year of Change. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, shared his insights in the CPHI Annual Report 202 ...
A weekly injection could replace painful daily treatment for rare genetic condition
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...
Why Eli Lilly and Company (LLY) Is Among the Best Long Term Low Risk Stocks to Buy Now
We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...
EurekAlert!10d
A weekly injection could replace painful daily treatment for rare fat disorder
“These patients are severely ill and face markedly reduced life expectancy ... and obesity drug tirzepatide (the active ingredient in Zepbound and Mounjaro) could improve CGL, as it improves ...
Atlanta Black Star News on MSN9d
‘Single White Female’ Star Bridget Fonda Looks Unrecognizable In Rare Sighting as Fans Point Out Her Drastic Transformation
It's been over three decades since actress Bridget Fonda's lead role in "Single White Female." She starred in several films and projects before taking a ...
Demand for loose skin surgery rises with GLP-1 weight loss meds
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients seeking loose skin surgeries ...
Novo Nordisk Stock Jumps After Earnings. The Weight-Loss Drugmaker Has Growth Concerns.
Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition ...